Expertise in
1
conditions

Dr. Victor M. Vargas

Hospital Medicine
701 W Cocoa Beach Cswy, 
Cocoa Beach, FL 
Accepting New Patients
Offers Telehealth
Expertise in
1
conditions
701 W Cocoa Beach Cswy, 
Cocoa Beach, FL 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Victor Vargas is a Hospital Medicine provider in Cocoa Beach, Florida. Dr. Vargas is highly rated in 1 condition, according to our data. His top areas of expertise are Liver Failure, Gastric Bypass, and Hip Replacement. Dr. Vargas is currently accepting new patients.

His clinical research consists of co-authoring 100 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Hospital Medicine
Licenses
Hospitalist in FL
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO

Locations

701 W Cocoa Beach Cswy, Cocoa Beach, FL 32931

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects With Nonalcoholic Steatohepatitis
A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects With Nonalcoholic Steatohepatitis
Enrollment Status: Terminated
Publish Date: October 01, 2024
Intervention Type: Drug
Study Drug: Obeticholic Acid
Study Phase: Phase 3
Characteristics and Management of Acute Kidney Injury in Hospitalized Patients With Cirrhosis: a Multicenter Intercontinental Observational Prospective Study: The International Club of Ascites GLOBAL AKI Project
Characteristics and Management of Acute Kidney Injury in Hospitalized Patients With Cirrhosis: a Multicenter Intercontinental Observational Prospective Study: The International Club of Ascites GLOBAL AKI Project
Enrollment Status: Completed
Publish Date: January 30, 2024
Intervention Type: Combination product
Efficacy of the Combination of Simvastatin Plus Rifaximin in Patients With Decompensated Cirrhosis to Prevent ACLF Development: a Multicenter, Double-blind, Placebo Controlled Randomized Clinical Trial
Efficacy of the Combination of Simvastatin Plus Rifaximin in Patients With Decompensated Cirrhosis to Prevent ACLF Development: a Multicenter, Double-blind, Placebo Controlled Randomized Clinical Trial
Enrollment Status: Completed
Publish Date: May 24, 2023
Intervention Type: Drug
Study Drugs: Simvastatin, Rifaximin
Study Phase: Phase 2/Phase 3
A Phase 4, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study Evaluating the Effect of Obeticholic Acid on Clinical Outcomes in Patients With Primary Biliary Cholangitis
A Phase 4, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study Evaluating the Effect of Obeticholic Acid on Clinical Outcomes in Patients With Primary Biliary Cholangitis
Enrollment Status: Terminated
Publish Date: March 09, 2023
Intervention Type: Drug
Study Drug: Obeticholic Acid 
Study Phase: Phase 4
A 52-week, Placebo-controlled, Randomized, Phase 3 Study to Evaluate the Safety and Efficacy of Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and an Inadequate Response to or an Intolerance to Ursodeoxycholic Acid (UDCA)
A 52-week, Placebo-controlled, Randomized, Phase 3 Study to Evaluate the Safety and Efficacy of Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and an Inadequate Response to or an Intolerance to Ursodeoxycholic Acid (UDCA)
Enrollment Status: Completed
Publish Date: August 02, 2022
Intervention Type: Drug
Study Phase: Phase 3
Safety and Tolerability of the Combination of Simvastatin Plus Rifaximin in Patients With Decompensated Cirrhosis: a Multicenter, Double-blind, Placebo Controlled Randomized Clinical Trial.
Safety and Tolerability of the Combination of Simvastatin Plus Rifaximin in Patients With Decompensated Cirrhosis: a Multicenter, Double-blind, Placebo Controlled Randomized Clinical Trial.
Enrollment Status: Completed
Publish Date: March 28, 2019
Intervention Type: Other, Drug
Study Phase: Phase 2
View 5 Less Clinical Trials

100 Total Publications

PD-L1 and the risk of bacterial infection in patients with chronic liver diseases: An international multicohort study.
PD-L1 and the risk of bacterial infection in patients with chronic liver diseases: An international multicohort study.
Journal: JHEP reports : innovation in hepatology
Published: June 28, 2025
Similar Doctors
Expertise in
17
conditions
Dr. Zaw Htay
Infectious Disease | Hospital Medicine
Expertise in
17
conditions
Dr. Zaw Htay
Infectious Disease | Hospital Medicine

Health First Medical Group LLC

1350 Hickory St, 
Melbourne, FL 
 (18.8 miles away)
321-434-1401
Experience:
44+ years
Languages Spoken:
English, Burmese
See accepted insurances
Accepting New Patients

Zaw Htay is an Infectious Disease specialist and a Hospital Medicine provider in Melbourne, Florida. Dr. Htay has been practicing medicine for over 44 years is highly rated in 17 conditions, according to our data. His top areas of expertise are Hospital-Acquired Pneumonia, Cellulitis, Pneumonia, and Lymphangitis. Dr. Htay is currently accepting new patients.

Expertise in
20
conditions
Dr. Aluino L. Ochoa
General Surgery | Intensive Care Medicine | Pulmonary Medicine
Expertise in
20
conditions
Dr. Aluino L. Ochoa
General Surgery | Intensive Care Medicine | Pulmonary Medicine

Apogee Medical Group, Florida Inc

951 N Washington Ave, 
Titusville, FL 
 (22.3 miles away)
321-268-6111
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Aluino Ochoa is a General Surgeon and an Intensive Care Medicine provider in Titusville, Florida. Dr. Ochoa is highly rated in 20 conditions, according to our data. His top areas of expertise are Lung Metastases, Necrosis, Vitamin D Deficiency, Endoscopy, and Advanced Bronchoscopy. Dr. Ochoa is currently accepting new patients.

Expertise in
1
conditions
Dr. Lan T. Phan
Hospital Medicine | Nephrology
Expertise in
1
conditions
Dr. Lan T. Phan
Hospital Medicine | Nephrology

Health First Medical Group LLC

701 W Cocoa Beach Cswy, 
Cocoa Beach, FL 
 (0.1 miles away)
321-799-7128
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Lan Phan is a Hospital Medicine specialist and a Nephrologist in Cocoa Beach, Florida. Dr. Phan is highly rated in 1 condition, according to our data. Her top areas of expertise are Renovascular Hypertension, Low Sodium Level, Necrosis, Endoscopy, and Hip Replacement. Dr. Phan is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Vargas's expertise for a condition
ConditionClose
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile